Lebogang Mokotedi Selected Research

Lebogang Mokotedi Research Topics

6	Inflammation (Inflammations) 01/2023 - 12/2019
4	Arthritis (Polyarthritis) 01/2023 - 12/2019
2	Left Ventricular Dysfunction 01/2023 - 12/2022
2	Experimental Arthritis 01/2023 - 12/2019
2	Necrosis 12/2019 - 02/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Chemical and Drug Induced Liver Injury 01/2023
1	Fibrosis (Cirrhosis) 11/2021
1	Ventricular Remodeling 02/2017
1	Hypertrophy 02/2017

4	CollagenIBA 01/2023 - 02/2017
3	incomplete Freund's adjuvantIBA 01/2023 - 12/2019
3	Collagen Type II (Type II Collagen)IBA 01/2023 - 12/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 11/2021
2	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2019
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 12/2022
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2022 - 12/2019
2	Etanercept (Enbrel)FDA Link 01/2022 - 11/2021
1	C.I. direct red 80IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	EnzymesIBA 01/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 12/2022
1	ElementsIBA 12/2022
1	ConnectinIBA 12/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2022
1	protein phosphatase 5IBA 12/2022
1	PTX3 proteinIBA 12/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 12/2019
1	InterleukinsIBA 12/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2017

2	Therapeutics 01/2023 - 12/2022